The role of PET in the surgical management of malignant pleural mesothelioma

Lung Cancer

Volumn 49, Issue SUPPL. 1, 2005, Pages

  Flores, Raja M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Malignant pleural mesothelioma; PET; Tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 20444415663     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.03.007     Document Type: Article

References (8)

1. R. Heelan, V. Rusch, C. Begg, D. Panicek, J. Caravelli, and C. Eisen Malignant pleural mesothelioma: comparison of CT and MR imaging for staging AJR 173 1999 1039 1047
2. E.J. Patz, K. Shaffer, D.R. Piwnica-Worms, M. Jochelson, M. Sarin, and D.J. Sugarbaker Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability AJR Am J Roentgenol 159 1992 961 966
3. R. Flores, T. Akhurst, M. Gonen, S. Larson, and V.W. Rusch Positron emission tomography (PET) defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma (MPM) J Thorac Cardiovasc Surg 126 2003 11 16
4. R. Flores, T. Akhurst, M. Gonen, S. Larson, and V. Rusch FDG-PET predicts survival in patients with malignant pleural mesothelioma ASCO Proceedings, 2495 Chicago, IL 2003
5. V.W. Rusch, and E. Venkatraman The importance of surgical staging in the treatment of malignant pleural mesothelioma J Thorac Cardiovasc Surg 111 1996 815 825
6. D.J. Sugarbaker, R.M. Flores, M.T. Jaklitsch, W.G. Richards, G.M. Strauss, and J.M. Corson Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 65
7. V. Rusch, K. Rosenzweig, E. Venkatraman, L. Leon, A. Raben, and L. Harrison A Phase II trial of surgical resection and adjuvant high dose hemithoracic radiation for malignant pleural mesothelioma J Thorac Cardiovasc Surg 122 2001 788 795
8. American Joint Committee on Cancer: AJCC Cancer Staging Handbook. New York, Berlin: Springer; 2002.